TYPE 1 DIABETES MELLITUS

This small study tested a new tool called InsuLearn that helps people with type 1 diabetes calculate their insulin doses without counting carbohydrates. Seven adults on multiple daily injections participated in a 24-hour crossover trial comparing InsuLearn to usual care. The goal…

This study tested whether multiple infusions of a stem cell product called PROCHYMAL could safely help preserve the body's ability to make insulin in people recently diagnosed with type 1 diabetes. The trial enrolled 63 participants aged 12 to 35 who had been diagnosed within the…

This study looked at how well the TouchCare Nano automated insulin delivery system works for children and teens with type 1 diabetes in everyday life. Researchers tracked 76 kids aged 6 to 18 over about six months to see if the system helped them keep their blood sugar in a healt…

This early-stage trial tested a new immunotherapy (IBC with MAS-1) in 21 adults recently diagnosed with type 1 diabetes. The goal was to see if the treatment is safe and can retrain the immune system to stop attacking the pancreas, potentially preserving the body's ability to mak…

This study tested a hybrid closed loop system that combines an insulin pump with a continuous glucose monitor to automatically adjust insulin delivery. 30 adults with type 1 diabetes used the system for a year to see if it improved blood sugar control and quality of life. The goa…

This study tested a treatment called REACT (rilparencel) for people with type 1 or 2 diabetes who also have chronic kidney disease. The treatment uses a person's own kidney cells to try to slow down kidney damage. 53 adults took part, and the study looked at safety and whether it…

This study tested an artificial pancreas system that learns a person's exercise patterns to prevent low blood sugar (hypoglycemia) in adults with type 1 diabetes. Fifteen participants used both a standard and an experimental version of the system during exercise sessions. The goa…

This study tested whether a continuous glucose monitor (CGM) combined with a diabetes management platform (DMP) can help older adults (65+) with type 1 diabetes reduce low blood sugar episodes. The DMP automatically sends glucose and insulin data to a system that gives dose adjus…

This study tested whether a mobile app-based education program helps teenagers with type 1 diabetes manage their condition better. 96 teens aged 12-18 were split into two groups: one used the app for diabetes education, the other received standard care. The goal was to see if the…

This study tested a simple tool—a map showing where to inject insulin—to help people with diabetes avoid developing fatty lumps under the skin (lipohypertrophy) and improve blood sugar control. 170 adults who had been using insulin for at least six months took part. Half received…

This study tested a device called Cap INSULCLOCK, which attaches to insulin pens and automatically records injections and glucose data. 42 adults with type 1 diabetes used the device to see if it improved blood sugar control and satisfaction. The goal was to help people manage th…

This study tested two different automated insulin delivery systems (Medtronic 780G and Tandem t:slim X2) in 20 adolescents with type 1 diabetes. The goal was to see how well each system handled unannounced meals—meals eaten without pre-bolusing insulin. The results help doctors u…

This study tested whether the drug finerenone can slow kidney damage in people with type 1 diabetes and chronic kidney disease. About 241 adults took either finerenone or a placebo pill for 6 months, along with their usual treatments. Researchers measured changes in urine protein…

This study looked at whether adding a community health worker to the care team helps children with type 1 diabetes. 84 children with type 1 diabetes took part. The goal was to see if this support improves blood sugar control, reduces hospital visits, and helps kids attend more do…

This study tested two small devices—Coolsense (cold only) and Buzzy (cold plus vibration)—to see if they could lower pain and fear in children aged 6–12 during insulin injections. 90 kids with type 1 diabetes were split into three groups: one used Coolsense, one used Buzzy, and o…

This study tested a home video program called REDCHiP to help parents of young children (ages 2-6) with type 1 diabetes feel less afraid of hypoglycemia (low blood sugar). About 400 families took part, comparing the video program to a control group. The goal was to reduce parents…

This study tested a program to help teens and young adults (ages 17-23) with type 1 diabetes improve how they talk to doctors when moving from pediatric to adult care. 52 participants were split into two groups: one got communication and transition training, the other got standar…

This study looked at 186 pregnant women with type 1 or type 2 diabetes to understand how fats (lipids) in the mother's and baby's blood relate to birth weight. Even when blood sugar is well-controlled, babies of diabetic mothers are often larger than average, which can cause deli…

This study looked at 11 teens with type 1 diabetes to see how high-fat, high-protein meals affect their blood sugar. Researchers tested different ways of counting nutrients to adjust insulin doses. The goal was to find better methods for managing blood sugar after eating.

This study examined how the menstrual cycle affects insulin sensitivity and blood sugar control in 77 women with type 1 diabetes. Researchers analyzed data from continuous glucose monitors and insulin pumps to compare the follicular and luteal phases. The goal is to help women be…

This study explored how non-caloric artificial sweeteners (like those in diet sodas) might affect body fat, metabolism, and blood sugar control in young people aged 5-17 with type 1 diabetes. Researchers measured body composition, blood markers, and diet habits in 21 participants…

This study followed over 8,600 newborns at genetic risk for type 1 diabetes to identify environmental triggers like infections or diet that may cause the disease. Researchers tracked the appearance of diabetes-related autoantibodies and later development of type 1 diabetes. The g…

This study surveyed 166 adults with type 1 diabetes to learn what factors influence their choice of hybrid closed-loop (artificial pancreas) systems. Participants were people already using, waiting to start, or considering this technology. The goal was to better understand patien…